Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ascertain
AddedFeb 17, 2024
UpdatedMay 28, 2026
Ascertain

Ascertain

Seed

Agentic AI platform automating healthcare administrative workflows with measurable ROI in under 90 days.

HQ
New York City, NY, US
Founded
2022
Overview
Analysis
Compare
Fundraising
Employees
News
Website

Ascertain is a healthcare technology company that builds an agentic AI platform to automate administrative workflows including prior authorizations, referrals, eligibility checks, care coordination, and revenue cycle operations for health systems, payers, and provider groups. Founded in 2022 as a partnership between Northwell Health and Aegis Ventures, and backed by Deerfield Management, Ascertain uses human-in-the-loop AI agents that integrate with existing enterprise systems to deliver measurable ROI in under 90 days.

The platform automates complex, forms-heavy workflows across prior authorizations, eligibility verification, care coordination, discharge planning, and payer communications while maintaining human-in-the-loop oversight and built-in traceability. Proven results include a 95% reduction in prior authorization workload across 100+ oncology clinics with The Oncology Institute, an 80% reduction in user clicks and 67% faster authorization submissions at Northwell Health, and a partnership with Cardiovascular Associates of America covering 460+ cardiologists across 100+ locations.

Ascertain - Products & Services

  • Ascertain Tech-Enabled Services logo

    Ascertain Tech-Enabled Services

    Outsourced workflow operations where Ascertain Assistants run the Automate platform for customers.

Ascertain - Similar Companies

Anterior logo

Anterior

anterior.com

TriFetch logo

TriFetch

trifetch.ai

Adonis logo

Adonis

adonis.io

Shasta Health logo

Shasta Health

shasta.health

Fuse logo

Fuse

fuseinsight.com

Wedge logo

Wedge

wedge.health

Lassie logo

Lassie

lassie.ai

Basata logo

Basata

basata.ai

Forus logo

Forus

forus.com

Frontier Health logo

Frontier Health

frontierhealth.ai

Akasa logo

Akasa

akasa.com

Truco logo

Truco

truco.ai

Autonomize logo

Autonomize

autonomize.ai

Sohar Health logo

Sohar Health

soharhealth.com

Readily logo

Readily

readily.co

Ascertain - Quick Facts

Who are Ascertain's competitors?

Companies similar to Ascertain include Anterior, TriFetch, Adonis and Shasta Health.

When was Ascertain founded?

Ascertain was founded in 2022.

Where is Ascertain's headquarters located?

Ascertain's headquarters is located in New York City, NY, US.

When was Ascertain's last funding round?

Ascertain's most recent funding round was for $100M (USD) in April 2022.

How much has Ascertain raised to-date?

As of Apr 12, 2022, Ascertain has raised a total of $100M (USD).

How many employees does Ascertain have?

Ascertain has 6 employees as of Feb 4, 2024.

Ascertain - Classification

Industry
  • Artificial Intelligence
  • Healthcare IT
Model
  • B2B SaaS
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end